Derek Meisner
2023 - Acumen Pharmaceuticals
In 2023, Derek Meisner earned a total compensation of $1.5M as Chief Legal Officer at Acumen Pharmaceuticals, a 15% increase compared to previous year.
Compensation breakdown
Bonus | $45,000 |
---|---|
Non-Equity Incentive Plan | $236,945 |
Option Awards | $559,944 |
Salary | $455,663 |
Stock Awards | $163,748 |
Other | $15,337 |
Total | $1,476,637 |
Meisner received $559.9K in option awards, accounting for 38% of the total pay in 2023.
Meisner also received $45K in bonus, $236.9K in non-equity incentive plan, $455.7K in salary, $163.7K in stock awards and $15.3K in other compensation.
Rankings
In 2023, Derek Meisner's compensation ranked 805th out of 2,978 executives tracked by ExecPay. In other words, Meisner earned more than 73.0% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 805 | 73rd |
Manufacturing | 471 | 71st |
Chemicals And Allied Products | 321 | 65th |
Drugs | 313 | 64th |
Biological Products, Except Diagnostic Substances | 100 | 53rd |
Meisner's colleagues
We found two more compensation records of executives who worked with Derek Meisner at Acumen Pharmaceuticals in 2023.
News
Acumen Pharmaceuticals CEO Daniel O'Connell's 2023 pay jumps 48% to $3.9M
April 22, 2024
Acumen Pharmaceuticals CEO Daniel O'Connell's 2022 pay jumps 80% to $2.7M
April 27, 2023
X4 Pharmaceuticals CEO Paula Ragan's 2021 pay slips 15% to $2.1M
April 25, 2022
X4 Pharmaceuticals CEO Paula Ragan's 2020 pay rises 1% to $2.5M
April 20, 2021